FDA approves first treatment for BCG-unresponsive bladder cancer
The FDA has approved the first treatment option specifically for patients with BCG-unresponsive non-muscle invasive bladder cancer.
The FDA has approved the first treatment option specifically for patients with BCG-unresponsive non-muscle invasive bladder cancer.